GlassScriptPhysician profile
Javaria Asif
NPI 1538355441
$8,485.71
in general payments reported to CMS, 2019-2025
60 companies · $1,539 in 2025
The $1,539 reported for 2025 was more than what 92% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,004 · 2020: $701 · 2021: $1,274 · 2022: $1,239 · 2023: $1,237 · 2024: $1,491 · 2025: $1,539.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,268.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,267.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,313.59 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Lilly USA, LLC | $943.04 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Abbvie INC. | $719.12 | 2021-2025 | Vraylar, Ubrelvy, Synthroid |
| Boehringer Ingelheim Pharmaceuticals, INC. | $666.73 | 2019-2025 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $551.52 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Amgen INC. | $522.43 | 2019-2025 | Evenity, Repatha, Otezla |
| Glaxosmithkline, LLC. | $447.84 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Dexcom, INC. | $305.97 | 2024-2025 | Dexcom G6 Transmitter |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $228.85 | 2019-2025 | Xifaxan, Trulance |
| Daiichi Sankyo INC. | $219.90 | 2019-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $219.40 | 2020-2022 | |
| Exact Sciences Corporation | $217.71 | 2023-2025 | Cologuard Collection Kit |
| Allergan, INC. | $197.25 | 2019-2020 | |
| Pfizer INC. | $181.94 | 2022-2025 | |
| Amarin Pharma, INC. | $116.96 | 2019-2022 |
Show all 60 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Javaria Asif listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.